Amedisys says its second-quarter earnings will be down from its original projections, partially due to SEC and U.S. Senate investigations into Medicare reimbursements. The company is now forecasting e…
Amedisys says its second-quarter earnings will be down from its original projections, partially due to SEC and U.S. Senate investigations into Medicare reimbursements. The company is now forecasting e…